Global and United States Pet Pharmaceuticals Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Pet pharmaceutical refers specifically to medicines given to pets.

In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.

In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

Market Analysis and Insights: Global and United States Pet Pharmaceuticals Market
This report focuses on global and United States Pet Pharmaceuticals market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Pet Pharmaceuticals market size is estimated to be worth US$ 15350 million in 2022 and is forecast to a readjusted size of US$ 23040 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, by Type, Antiparasitic accounting for % of the Pet Pharmaceuticals global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Prevention was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.

Global Pet Pharmaceuticals Scope and Market Size
Pet Pharmaceuticals market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Pet Pharmaceuticals market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Pet Pharmaceuticals market is segmented into
    Antiparasitic
    Biological Products
    Antibacterial
    Others

Segment by Application, the Pet Pharmaceuticals market is segmented into
    Prevention
    Treatment

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC

 1 Study Coverage
    1.1 Pet Pharmaceuticals Product Introduction
    1.2 Global Pet Pharmaceuticals Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Pet Pharmaceuticals Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Pet Pharmaceuticals Sales in Volume for the Year 2017-2028
    1.3 United States Pet Pharmaceuticals Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Pet Pharmaceuticals Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Pet Pharmaceuticals Sales in Volume for the Year 2017-2028
    1.4 Pet Pharmaceuticals Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Pet Pharmaceuticals in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Pet Pharmaceuticals Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Pet Pharmaceuticals Market Dynamics
        1.5.1 Pet Pharmaceuticals Industry Trends
        1.5.2 Pet Pharmaceuticals Market Drivers
        1.5.3 Pet Pharmaceuticals Market Challenges
        1.5.4 Pet Pharmaceuticals Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Pet Pharmaceuticals Market Segment by Type
        2.1.1 Antiparasitic
        2.1.2 Biological Products
        2.1.3 Antibacterial
        2.1.4 Others
    2.2 Global Pet Pharmaceuticals Market Size by Type
        2.2.1 Global Pet Pharmaceuticals Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Pet Pharmaceuticals Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Pet Pharmaceuticals Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Pet Pharmaceuticals Market Size by Type
        2.3.1 United States Pet Pharmaceuticals Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Pet Pharmaceuticals Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Pet Pharmaceuticals Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Pet Pharmaceuticals Market Segment by Application
        3.1.1 Prevention
        3.1.2 Treatment
    3.2 Global Pet Pharmaceuticals Market Size by Application
        3.2.1 Global Pet Pharmaceuticals Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Pet Pharmaceuticals Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Pet Pharmaceuticals Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Pet Pharmaceuticals Market Size by Application
        3.3.1 United States Pet Pharmaceuticals Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Pet Pharmaceuticals Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Pet Pharmaceuticals Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Pet Pharmaceuticals Competitor Landscape by Company
    4.1 Global Pet Pharmaceuticals Market Size by Company
        4.1.1 Top Global Pet Pharmaceuticals Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Pet Pharmaceuticals Revenue by Manufacturer (2017-2022)
        4.1.3 Global Pet Pharmaceuticals Sales by Manufacturer (2017-2022)
        4.1.4 Global Pet Pharmaceuticals Price by Manufacturer (2017-2022)
    4.2 Global Pet Pharmaceuticals Concentration Ratio (CR)
        4.2.1 Pet Pharmaceuticals Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pet Pharmaceuticals in 2021
        4.2.3 Global Pet Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Pet Pharmaceuticals Manufacturing Base Distribution, Product Type
        4.3.1 Global Pet Pharmaceuticals Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Pet Pharmaceuticals Product Type
        4.3.3 Date of International Manufacturers Enter into Pet Pharmaceuticals Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Pet Pharmaceuticals Market Size by Company
        4.5.1 Top Pet Pharmaceuticals Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Pet Pharmaceuticals Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Pet Pharmaceuticals Sales by Players (2020, 2021 & 2022)

 5 Global Pet Pharmaceuticals Market Size by Region
    5.1 Global Pet Pharmaceuticals Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Pet Pharmaceuticals Market Size in Volume by Region (2017-2028)
        5.2.1 Global Pet Pharmaceuticals Sales in Volume by Region: 2017-2022
        5.2.2 Global Pet Pharmaceuticals Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Pet Pharmaceuticals Market Size in Value by Region (2017-2028)
        5.3.1 Global Pet Pharmaceuticals Sales in Value by Region: 2017-2022
        5.3.2 Global Pet Pharmaceuticals Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Pet Pharmaceuticals Market Size YoY Growth 2017-2028
        6.1.2 North America Pet Pharmaceuticals Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Pet Pharmaceuticals Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Pet Pharmaceuticals Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Pet Pharmaceuticals Market Size YoY Growth 2017-2028
        6.3.2 Europe Pet Pharmaceuticals Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Pet Pharmaceuticals Market Size YoY Growth 2017-2028
        6.4.2 Latin America Pet Pharmaceuticals Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Pet Pharmaceuticals Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Pet Pharmaceuticals Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Zoetis
        7.1.1 Zoetis Corporation Information
        7.1.2 Zoetis Description and Business Overview
        7.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Zoetis Pet Pharmaceuticals Products Offered
        7.1.5 Zoetis Recent Development
    7.2 Boehringer Ingelheim
        7.2.1 Boehringer Ingelheim Corporation Information
        7.2.2 Boehringer Ingelheim Description and Business Overview
        7.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Boehringer Ingelheim Pet Pharmaceuticals Products Offered
        7.2.5 Boehringer Ingelheim Recent Development
    7.3 Merck
        7.3.1 Merck Corporation Information
        7.3.2 Merck Description and Business Overview
        7.3.3 Merck Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Merck Pet Pharmaceuticals Products Offered
        7.3.5 Merck Recent Development
    7.4 Elanco
        7.4.1 Elanco Corporation Information
        7.4.2 Elanco Description and Business Overview
        7.4.3 Elanco Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Elanco Pet Pharmaceuticals Products Offered
        7.4.5 Elanco Recent Development
    7.5 Virbac
        7.5.1 Virbac Corporation Information
        7.5.2 Virbac Description and Business Overview
        7.5.3 Virbac Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Virbac Pet Pharmaceuticals Products Offered
        7.5.5 Virbac Recent Development
    7.6 Dechra Veterinary Products
        7.6.1 Dechra Veterinary Products Corporation Information
        7.6.2 Dechra Veterinary Products Description and Business Overview
        7.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Dechra Veterinary Products Pet Pharmaceuticals Products Offered
        7.6.5 Dechra Veterinary Products Recent Development
    7.7 Ceva
        7.7.1 Ceva Corporation Information
        7.7.2 Ceva Description and Business Overview
        7.7.3 Ceva Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Ceva Pet Pharmaceuticals Products Offered
        7.7.5 Ceva Recent Development
    7.8 Vetoquinol
        7.8.1 Vetoquinol Corporation Information
        7.8.2 Vetoquinol Description and Business Overview
        7.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Vetoquinol Pet Pharmaceuticals Products Offered
        7.8.5 Vetoquinol Recent Development
    7.9 Ouro Fino Saude
        7.9.1 Ouro Fino Saude Corporation Information
        7.9.2 Ouro Fino Saude Description and Business Overview
        7.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Ouro Fino Saude Pet Pharmaceuticals Products Offered
        7.9.5 Ouro Fino Saude Recent Development
    7.10 Norbrook
        7.10.1 Norbrook Corporation Information
        7.10.2 Norbrook Description and Business Overview
        7.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Norbrook Pet Pharmaceuticals Products Offered
        7.10.5 Norbrook Recent Development
    7.11 Jindun
        7.11.1 Jindun Corporation Information
        7.11.2 Jindun Description and Business Overview
        7.11.3 Jindun Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Jindun Pet Pharmaceuticals Products Offered
        7.11.5 Jindun Recent Development
    7.12 Chopperlvya Animal Health
        7.12.1 Chopperlvya Animal Health Corporation Information
        7.12.2 Chopperlvya Animal Health Description and Business Overview
        7.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Chopperlvya Animal Health Products Offered
        7.12.5 Chopperlvya Animal Health Recent Development
    7.13 CAHIC
        7.13.1 CAHIC Corporation Information
        7.13.2 CAHIC Description and Business Overview
        7.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 CAHIC Products Offered
        7.13.5 CAHIC Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Pet Pharmaceuticals Industry Chain Analysis
    8.2 Pet Pharmaceuticals Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Pet Pharmaceuticals Distributors
    8.3 Pet Pharmaceuticals Production Mode & Process
    8.4 Pet Pharmaceuticals Sales and Marketing
        8.4.1 Pet Pharmaceuticals Sales Channels
        8.4.2 Pet Pharmaceuticals Distributors
    8.5 Pet Pharmaceuticals Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Pet Pharmaceuticals CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Pet Pharmaceuticals Market Trends
    Table 3. Pet Pharmaceuticals Market Drivers
    Table 4. Pet Pharmaceuticals Market Challenges
    Table 5. Pet Pharmaceuticals Market Restraints
    Table 6. Global Pet Pharmaceuticals Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pet Pharmaceuticals Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pet Pharmaceuticals Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pet Pharmaceuticals Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pet Pharmaceuticals Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pet Pharmaceuticals Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Pet Pharmaceuticals Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Pet Pharmaceuticals Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Pet Pharmaceuticals Sales Share by Manufacturer, 2017-2022
    Table 15. Global Pet Pharmaceuticals Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Pet Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Pet Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Pharmaceuticals as of 2021)
    Table 18. Top Players of Pet Pharmaceuticals in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Pet Pharmaceuticals Product Type
    Table 20. Date of International Manufacturers Enter into Pet Pharmaceuticals Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Pet Pharmaceuticals Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Pet Pharmaceuticals Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Pet Pharmaceuticals Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Pet Pharmaceuticals Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Pet Pharmaceuticals Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Pet Pharmaceuticals Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Pet Pharmaceuticals Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Pet Pharmaceuticals Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Pet Pharmaceuticals Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Pet Pharmaceuticals Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Pet Pharmaceuticals Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Pet Pharmaceuticals Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Pet Pharmaceuticals Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Pet Pharmaceuticals Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Pet Pharmaceuticals Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Pet Pharmaceuticals Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Pet Pharmaceuticals Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Pet Pharmaceuticals Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Pet Pharmaceuticals Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Pet Pharmaceuticals Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Zoetis Corporation Information
    Table 43. Zoetis Description and Business Overview
    Table 44. Zoetis Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Zoetis Pet Pharmaceuticals Product
    Table 46. Zoetis Recent Development
    Table 47. Boehringer Ingelheim Corporation Information
    Table 48. Boehringer Ingelheim Description and Business Overview
    Table 49. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Boehringer Ingelheim Product
    Table 51. Boehringer Ingelheim Recent Development
    Table 52. Merck Corporation Information
    Table 53. Merck Description and Business Overview
    Table 54. Merck Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Merck Product
    Table 56. Merck Recent Development
    Table 57. Elanco Corporation Information
    Table 58. Elanco Description and Business Overview
    Table 59. Elanco Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Elanco Product
    Table 61. Elanco Recent Development
    Table 62. Virbac Corporation Information
    Table 63. Virbac Description and Business Overview
    Table 64. Virbac Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Virbac Product
    Table 66. Virbac Recent Development
    Table 67. Dechra Veterinary Products Corporation Information
    Table 68. Dechra Veterinary Products Description and Business Overview
    Table 69. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Dechra Veterinary Products Product
    Table 71. Dechra Veterinary Products Recent Development
    Table 72. Ceva Corporation Information
    Table 73. Ceva Description and Business Overview
    Table 74. Ceva Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Ceva Product
    Table 76. Ceva Recent Development
    Table 77. Vetoquinol Corporation Information
    Table 78. Vetoquinol Description and Business Overview
    Table 79. Vetoquinol Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Vetoquinol Product
    Table 81. Vetoquinol Recent Development
    Table 82. Ouro Fino Saude Corporation Information
    Table 83. Ouro Fino Saude Description and Business Overview
    Table 84. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Ouro Fino Saude Product
    Table 86. Ouro Fino Saude Recent Development
    Table 87. Norbrook Corporation Information
    Table 88. Norbrook Description and Business Overview
    Table 89. Norbrook Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Norbrook Product
    Table 91. Norbrook Recent Development
    Table 92. Jindun Corporation Information
    Table 93. Jindun Description and Business Overview
    Table 94. Jindun Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Jindun Product
    Table 96. Jindun Recent Development
    Table 97. Chopperlvya Animal Health Corporation Information
    Table 98. Chopperlvya Animal Health Description and Business Overview
    Table 99. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Chopperlvya Animal Health Product
    Table 101. Chopperlvya Animal Health Recent Development
    Table 102. CAHIC Corporation Information
    Table 103. CAHIC Description and Business Overview
    Table 104. CAHIC Pet Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. CAHIC Product
    Table 106. CAHIC Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Pet Pharmaceuticals Customers List
    Table 110. Pet Pharmaceuticals Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pet Pharmaceuticals Product Picture
    Figure 2. Global Pet Pharmaceuticals Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pet Pharmaceuticals Market Size 2017-2028 (US$ Million)
    Figure 4. Global Pet Pharmaceuticals Sales 2017-2028 (K Units)
    Figure 5. United States Pet Pharmaceuticals Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Pet Pharmaceuticals Market Size 2017-2028 (US$ Million)
    Figure 7. United States Pet Pharmaceuticals Sales 2017-2028 (K Units)
    Figure 8. United States Pet Pharmaceuticals Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Pet Pharmaceuticals Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Pet Pharmaceuticals Report Years Considered
    Figure 11. Product Picture of Antiparasitic
    Figure 12. Product Picture of Biological Products
    Figure 13. Product Picture of Antibacterial
    Figure 14. Product Picture of Others
    Figure 15. Global Pet Pharmaceuticals Market Share by Type in 2022 & 2028
    Figure 16. Global Pet Pharmaceuticals Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Pet Pharmaceuticals Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Pet Pharmaceuticals Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Pet Pharmaceuticals Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Pet Pharmaceuticals Price by Type (2017-2028) & (US$/Unit)
    Figure 21. United States Pet Pharmaceuticals Market Share by Type in 2022 & 2028
    Figure 22. United States Pet Pharmaceuticals Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Pet Pharmaceuticals Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Pet Pharmaceuticals Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Pet Pharmaceuticals Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Pet Pharmaceuticals Price by Type (2017-2028) & (US$/Unit)
    Figure 27. Product Picture of Prevention
    Figure 28. Product Picture of Treatment
    Figure 29. Global Pet Pharmaceuticals Market Share by Application in 2022 & 2028
    Figure 30. Global Pet Pharmaceuticals Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Pet Pharmaceuticals Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Pet Pharmaceuticals Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Pet Pharmaceuticals Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Pet Pharmaceuticals Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Pet Pharmaceuticals Market Share by Application in 2022 & 2028
    Figure 36. United States Pet Pharmaceuticals Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Pet Pharmaceuticals Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Pet Pharmaceuticals Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Pet Pharmaceuticals Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Pet Pharmaceuticals Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Pet Pharmaceuticals Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Pet Pharmaceuticals Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Pet Pharmaceuticals Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Pet Pharmaceuticals Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Pet Pharmaceuticals Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Pet Pharmaceuticals Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Pet Pharmaceuticals Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Pet Pharmaceuticals Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Pet Pharmaceuticals Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Pet Pharmaceuticals Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Pet Pharmaceuticals Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Pet Pharmaceuticals Value Chain
    Figure 74. Pet Pharmaceuticals Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed

Pet pharmaceutical refers specifically to medicines given to pets.

In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.

In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.

Market Analysis and Insights: Global and United States Pet Pharmaceuticals Market
This report focuses on global and United States Pet Pharmaceuticals market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Pet Pharmaceuticals market size is estimated to be worth US$ 15350 million in 2022 and is forecast to a readjusted size of US$ 23040 million by 2028 with a CAGR of 7.0% during the review period. Fully considering the economic change by this health crisis, by Type, Antiparasitic accounting for % of the Pet Pharmaceuticals global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Prevention was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.

Global Pet Pharmaceuticals Scope and Market Size
Pet Pharmaceuticals market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pet Pharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Pet Pharmaceuticals market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Pet Pharmaceuticals market is segmented into
    Antiparasitic
    Biological Products
    Antibacterial
    Others

Segment by Application, the Pet Pharmaceuticals market is segmented into
    Prevention
    Treatment

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Pet Pharmaceuticals business, the date to enter into the Pet Pharmaceuticals market, Pet Pharmaceuticals product introduction, recent developments, etc.

The major vendors covered:
    Zoetis
    Boehringer Ingelheim
    Merck
    Elanco
    Virbac
    Dechra Veterinary Products
    Ceva
    Vetoquinol
    Ouro Fino Saude
    Norbrook
    Jindun
    Chopperlvya Animal Health
    CAHIC